These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14966727)

  • 21. Repeated measurement of intestinal permeability as an assessment of colitis severity in HLA-B27 transgenic rats.
    Kerr SW; Wolyniec WW; Filipovic Z; Nodop SG; Braza F; Winquist RJ; Noonan TC
    J Pharmacol Exp Ther; 1999 Nov; 291(2):903-10. PubMed ID: 10525115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose variation of hepatocyte growth factor and its effects on an animal model of TPN-induced liver injury.
    Katz MS; Thatch KA; Schwartz MZ
    J Surg Res; 2010 Oct; 163(2):294-8. PubMed ID: 20691983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of bone strength in HLA-B27 transgenic rats is characterized by a high bone turnover and is mainly osteoclast-driven.
    Rauner M; Thiele S; Fert I; Araujo LM; Layh-Schmitt G; Colbert RA; Hofbauer C; Bernhardt R; Bürki A; Schwiedrzik J; Zysset PK; Pietschmann P; Taurog JD; Breban M; Hofbauer LC
    Bone; 2015 Jun; 75():183-91. PubMed ID: 25746795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatocyte growth factor facilitates colonic mucosal repair in experimental ulcerative colitis in rats.
    Tahara Y; Ido A; Yamamoto S; Miyata Y; Uto H; Hori T; Hayashi K; Tsubouchi H
    J Pharmacol Exp Ther; 2003 Oct; 307(1):146-51. PubMed ID: 12954797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular effects of recombinant human interleukin-11 in the HLA-B27 rat model of inflammatory bowel disease.
    Peterson RL; Wang L; Albert L; Keith JC; Dorner AJ
    Lab Invest; 1998 Dec; 78(12):1503-12. PubMed ID: 9881950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TNFalpha blockade prevents the development of inflammatory bowel disease in HLA-B27 transgenic rats.
    Milia AF; Manetti M; Generini S; Polidori L; Benelli G; Cinelli M; Messerini L; Ibba-Manneschi L; Matucci-Cerinic M
    J Cell Mol Med; 2009 Jan; 13(1):164-76. PubMed ID: 18363845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatocyte growth factor up-regulates SGLT1 and GLUT5 gene expression after massive small bowel resection.
    Kato Y; Yu D; Schwartz MZ
    J Pediatr Surg; 1998 Jan; 33(1):13-5. PubMed ID: 9473090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of hepatocyte growth factor on intestinal permeability and bacterial translocation after small bowel transplantation in rat].
    Li K; Li N; Li J
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 May; 21(5):532-5. PubMed ID: 17578297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High prevalence of colorectal cancer in HLA-B27 transgenic F344 rats with chronic inflammatory bowel disease.
    Hammer RE; Richardson JA; Simmons WA; White AL; Breban M; Taurog JD
    J Investig Med; 1995 Jun; 43(3):262-8. PubMed ID: 7614072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronology of the effect of massive small bowel resection and hepatocyte growth factor (HGF) on intestinal adaptation.
    Katz MS; Thatch KA; Schwartz MZ
    J Surg Res; 2011 Dec; 171(2):399-403. PubMed ID: 21658720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Milk casein-based diet containing TGF-beta controls the inflammatory reaction in the HLA-B27 transgenic rat model.
    Schiffrin EJ; El Yousfi M; Faure M; Combaret L; Donnet A; Blum S; Obled C; Breuillé D
    JPEN J Parenter Enteral Nutr; 2005; 29(4 Suppl):S141-8; discussion S149-50, S184-8. PubMed ID: 15980276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intestinal inflammation and barrier function in HLA-B27/beta 2-microglobulin transgenic rats.
    Lundin PD; Ekström G; Erlansson M; Lundin S; Weström BR
    Scand J Gastroenterol; 1997 Jul; 32(7):700-5. PubMed ID: 9246711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of the inflammatory response and apoptosis using epidermal growth factor and hepatocyte growth factor in a liver injury model: a potential approach to the management and treatment of cholestatic liver disease.
    Thatch KA; Schwartz MZ; Yoo EY; Mendelson KG; Duke DS
    J Pediatr Surg; 2008 Dec; 43(12):2169-73. PubMed ID: 19040928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Supplemental calcium attenuates the colitis-related increase in diarrhea, intestinal permeability, and extracellular matrix breakdown in HLA-B27 transgenic rats.
    Schepens MA; Schonewille AJ; Vink C; van Schothorst EM; Kramer E; Hendriks T; Brummer RJ; Keijer J; van der Meer R; Bovee-Oudenhoven IM
    J Nutr; 2009 Aug; 139(8):1525-33. PubMed ID: 19535420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spontaneous intestinal inflammation and nitric oxide metabolism in HLA-B27 transgenic rats.
    Aiko S; Grisham MB
    Gastroenterology; 1995 Jul; 109(1):142-50. PubMed ID: 7797013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant human interleukin-11 restores smooth muscle function in the jejunum and colon of human leukocyte antigen-B27 rats with intestinal inflammation.
    Greenwood-Van Meerveld B; Venkova K; Keith JC
    J Pharmacol Exp Ther; 2001 Oct; 299(1):58-66. PubMed ID: 11561063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of hepatocyte growth factor on intestinal adaption in an experimental model of short bowel syndrome.
    Bagias G; Misiakos EP; Charalampopoulos A; Zavras N; Sakellariou S; Schizas D; Sukhotnik I; Giamarelos E; Pikoulis E
    Pediatr Surg Int; 2023 Jan; 39(1):80. PubMed ID: 36631569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocyte growth factor modulates the hepatic acute-phase response in thermally injured rats.
    Jeschke MG; Herndon DN; Wolf SE; DebRoy MA; Rai J; Thompson JC; Barrow RE
    Crit Care Med; 2000 Feb; 28(2):504-10. PubMed ID: 10708191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The preventive effect of recombinant human hepatocyte growth factor for hepatic steatosis in a rat model of short bowel syndrome.
    Yano K; Sugita K; Muto M; Matsukubo M; Onishi S; Kedoin C; Matsui M; Murakami M; Harumatsu T; Yamada K; Yamada W; Kumagai K; Ido A; Kaji T; Ieiri S
    J Pediatr Surg; 2022 Jul; 57(7):1286-1292. PubMed ID: 35396090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repeated enemas with hepatocyte growth factor selectively stimulate epithelial cell proliferation of injured mucosa in rats with experimental colitis.
    Setoyama H; Ido A; Numata M; Moriuchi A; Yamaji N; Tamai T; Funakawa K; Fujita H; Sakiyama T; Uto H; Oketani M; Tsubouchi H
    Life Sci; 2011 Aug; 89(7-8):269-75. PubMed ID: 21763320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.